首页> 外文会议>Annual Meeting of the National Mastitis Council >EXTRA-LABEL DRUG USE (ELDU) AND THE ANIMAL MEDICINAL DRUG USE CLARIFICATION ACT (AMDUCA) - How THEY IMPACT THE PRODUCER, VETERINARIAN, PROCESSOR AND CONSUMER
【24h】

EXTRA-LABEL DRUG USE (ELDU) AND THE ANIMAL MEDICINAL DRUG USE CLARIFICATION ACT (AMDUCA) - How THEY IMPACT THE PRODUCER, VETERINARIAN, PROCESSOR AND CONSUMER

机译:额外标签药物使用(ELDU)和动物药用药物使用澄清法(AMDUCA) - 它们如何影响生产者,兽医,处理器和消费者

获取原文

摘要

Therapy of animal disease has evolved significantly over the last 100 years. The introduction of antibiotics and other therapeutic agents has allowed us to treat infection and better alleviate pain and suffering. A wide variety of pharmaceutical agents are marketed for treatment of humans and animals. However, only a minority of these products are specifically labeled for use in animals with an even smaller subset being labeled for use in dairy cattle. Hence, occasions arise where a drug must be usedin an extra-label fashion, that is, in a manner other than specified on the product label or package insert. Extra-label drug use (ELDU) is routinely employed by veterinarians to alleviate pain and suffering in ill animals. The Animal Medicinal Drug Use Clarification Act (AMDUCA) was enacted in 1994 and provides guidelines for ELDU in animals.
机译:在过去的100年里,动物疾病的治疗显着发展。抗生素和其他治疗剂的引入使我们能够治疗感染,更好地缓解疼痛和痛苦。各种各样的药剂销售用于治疗人类和动物。然而,只有少数这些产品专门标记用于动物,具有甚至更小的子集被标记用于乳制品牛。因此,可能使用药物必须使用额外标签的方式,即以不同于产品标签或包装插入物的方式使用。兽医常常使用额外标签药物使用(ELDU)以减轻生病的动物疼痛和痛苦。 1994年制定了动物药用药物使用澄清法(Amduca),并为动物的Eldu提供了指导性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号